The invention relates to an intraocular lens comprising an optics body and a haptic which has a first component with a latching protrusion and a second component with a latching recess, the latching protrusion and the latching recess being arranged at a distance from one another when the haptic is arranged in a relaxed state and being configured to engage with one another when, proceeding from the relaxed state, the haptic is moved in the direction of the optics body into a completely compressed state of the haptic via a partially compressed state of the haptic, the haptic being formed by a single piece and having a haptic cutout which is delimited by the first component and the second component.

The invention relates to an intraocular lens comprising an optics body and a haptic which has a first component with a latching protrusion and a second component with a latching recess, the latching protrusion and the latching recess being arranged at a distance from one another when the haptic is arranged in a relaxed state and being configured to engage with one another when, proceeding from the relaxed state, the haptic is moved in the direction of the optics body into a completely compressed state of the haptic via a partially compressed state of the haptic, the haptic being formed by a single piece and having a haptic cutout which is delimited by the first component and the second component.

An accommodating intraocular lens (IOL) can be implanted either alone or as part of a two-part lens assembly. The IOL comprises an optic, a flexible membrane and a peripheral edge coupling the optic and the flexible membrane. The peripheral edge comprises an external circumferential surface having a height and a force transmitting area defined along a portion of the height of the external circumferential surface. A closed volume spaces apart the optic and the flexible membrane. The optic is axially displaced and the flexible membrane changes in curvature about a central axis when a radial compressive force is applied to the force transmitting area. A volume defined by the closed volume remains fixed when the optic is axially displaced and the flexible membrane changes in curvature and/or when the radial compressive force is applied to the force transmitting area.

An intraocular lens is provided that includes a refractive element and a mask. The refractive element has a first power in a first meridian and a second power greater than the first power in a second meridian. A magnitude of the first and second powers and a location of the first and second meridians are configured to correct astigmatism in a human eye. The mask is configured to block a substantial portion of light from passing through an annular region thereof and to permit a substantial portion of light to pass through a central aperture thereof to enhance an astigmatism correction rotational misplacement range and depth of focus.

A method is provided for use in reducing a size of halo effect in an ophthalmic lens. The method comprises: providing data indicative of a given ophthalmic lens with a first pattern providing prescribed vision improvement, processing said data indicative of the features of the first pattern and generating data indicative of a variation of at least one feature of the first pattern resulting in a second pattern which maintains said prescribed vision improvement and reduces a size of halo effect as compared to that of the lens with the first pattern.

An optical implantable member (102) is provided. The optical implantable member (102) includes an optic (104). The optic (104) includes an anterior surface (108) and a posterior surface (110), an optical centre (112) and a peripheral edge (116). The optical implantable member (102) is configured to be placed within a capsular bag of the eye. The optic (104) of the optical implantable member (102) includes a barrier (202). The barrier (202) is formed by a protrusion (202) on the posterior surface (110) of the optic (104). The protrusion (202) is concentric to an optical axis (114) of the optic (104). An outer wall (204 or 208) of the protrusion (202) is between the peripheral edge (116) and the optical centre (112). The barrier (202) restricts epithelial cells from migrating towards a central region of the capsular bag.

Intraocular implants and methods of forming intraocular implants are described herein. The intraocular implant can include a powered optic and a lens holder. The optic can be mechanically coupled to an inner periphery of the lens holder to form the intraocular implant. A portion of the lens holder can include a mask disposed about the optic to increase depth of focus in a human patient.

An ophthalmic implant for drug delivery. The implant includes a primary intracapsular device coupled to a secondary device, wherein, when implanted in a patient's eye, the primary intracapsular device is held in place by the patient's capsular bag and the secondary device is held in place by the primary intracapsular device. The implant may be inserted in the eye by injecting the primary intracapsular device into the eye either before or after attaching the secondary device to the primary intracapsular device, and subsequently positioning the joined secondary device and primary intracapsular device with the primary intracapsular device held in place by the patient's capsular bag and the secondary device held in place by the primary intracapsular device. The secondary device may be designed to hold a tertiary device that can be implanted and attached at the time of surgery or anytime postoperatively.

Embodiments of the present disclosure are directed to a phototherapy eye device. In an example, the phototherapy eye device includes a number of radioluminescent light sources and an anchor. Each radioluminescent light source includes an interior chamber coated with phosphor material, such as zinc sulfide, and containing a radioisotope material, such as gaseous tritium. The volume, shape, phosphor material, and radioisotope material are selected for emission of light at a particular wavelength and delivering a particular irradiance on the retina (when implanted in an eyeball). The wavelength is in the range of 400 to 600 nm and the irradiance is substantially 10.sup.9 to 10.sup.11 photons per second per cm.sup.2.

A method of modifying a refractive profile of an eye having an intraocular device implanted therein, wherein the method includes determining a corrected refractive profile for the eye based on an initial refractive profile, identifying one or more locations within the intraocular device based on the corrected refractive profile, and directing a pulsed laser beam at the locations to produce the corrected refractive profile. A system of modifying an intraocular device located within an eye, wherein the system includes a laser assembly and a controller coupled thereto. The laser assembly outputs a pulsed laser beam having a pulse width between 300 picoseconds and 10 femtoseconds. The controller directs the laser assembly to output the pulsed laser beam into the intraocular device. One or more slip zones are formed within the intraocular device in response thereto, and the slip zones are configured to modify a refractive profile of the intraocular device.